BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11416018)

  • 1. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
    Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
    Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.
    Jeay S; Sonenshein GE; Kelly PA; Postel-Vinay MC; Baixeras E
    Endocrinology; 2001 Jan; 142(1):147-56. PubMed ID: 11145577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line.
    Jeay S; Sonenshein GE; Postel-Vinay MC; Baixeras E
    Mol Endocrinol; 2000 May; 14(5):650-61. PubMed ID: 10809229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
    EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
    Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
    Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells.
    Grey A; Chen Q; Xu X; Callon K; Cornish J
    Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
    Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
    Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
    Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
    Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
    Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
    Thissen JP; Verniers J
    Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
    Xu X; Bennett SA; Ingram RL; Sonntag WE
    Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
    Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG
    Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action.
    Leung K; Rajkovic IA; Peters E; Markus I; Van Wyk JJ; Ho KK
    Endocrinology; 1996 Jul; 137(7):2694-702. PubMed ID: 8770888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
    Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
    Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells.
    Hu CL; Cowan RG; Harman RM; Quirk SM
    Mol Endocrinol; 2004 Feb; 18(2):326-38. PubMed ID: 14593075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.